Cadria 10mg Injection

About

Cadria 10mg Injection is a potent cytotoxic chemotherapy agent, likely belonging to the anthracycline class, commonly used in the treatment of various cancers. These drugs work by intercalating into DNA, inhibiting topoisomerase II, and generating free radicals, all of which lead to DNA damage and ultimately trigger apoptosis (programmed cell death) in rapidly dividing cancer cells. Cadria is effective against a broad spectrum of solid tumors and hematologic malignancies, often forming a crucial component of multi-drug chemotherapy regimens. Its mechanism of action makes it highly effective in reducing tumor size and preventing the spread of cancer, thereby improving survival rates and disease control in responsive patients. Due to its potent nature, administration requires careful medical supervision.

Uses

• Breast cancer
• Ovarian cancer
• Lung cancer
• Lymphomas and leukemias

Directions For Use

Administer intravenously under strict medical supervision, according to a specific chemotherapy regimen and dosage schedule.

Benefits

• Broad-spectrum anti-cancer activity
• Induces apoptosis in cancer cells
• Reduces tumor size effectively
• Improves survival rates in responsive cancers
• Part of established combination therapies
• Effective against rapidly dividing cells

Side Effects

• Nausea and vomiting
• Hair loss (alopecia)
• Fatigue
• Myelosuppression (low blood counts)
• Mucositis (inflammation of mucous membranes)
• Cardiotoxicity (heart damage)
• Extravasation (tissue damage at injection site)
• Rash
• Fever
• Diarrhea
• Appetite loss
• Darkening of urine

Safety Measures

• Alcohol - Avoid alcohol completely during treatment due to potential liver toxicity and increased risk of side effects.
• Pregnancy - Cadria is highly teratogenic and embryotoxic; it is strictly contraindicated during pregnancy.
• Breastfeeding - Cadria is excreted in breast milk and can cause serious adverse effects in infants; breastfeeding is contraindicated.
• Liver - Use with extreme caution in patients with hepatic impairment; significant dose reduction or contraindication may be necessary.
• Kidney - Use with caution in patients with renal impairment; monitor renal function, and dose adjustment may be needed.
• Lung - Monitor for pulmonary toxicity, though less common than cardiotoxicity, especially with prior radiation or other lung-toxic agents.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.